Ethiqa XR (buprenorphine) Extended-Release Injectable Suspension, 1.3mg/mL, C3

Supplied By: Fidelis Animal Health, Inc (FP-001)


SKU
072117


Unit of
Measure 3mL


Pack
Type Vial


Case
Qty 128

Login
{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}
Jul- 2025 Jun- 2025 May- 2025 Apr- 2025 Mar- 2025 Feb- 2025 Jan- 2025 Dec- 2024 Nov- 2024 Oct- 2024 Sep- 2024 Aug- 2024 Jul- 2024
{{purchaseHistoryItem}}


SKU 072117


Size 3mL

Case
Qty 128

Purchase History

Jul- 2025 {{productPurchaseHistory['072117'][0]}} Dec- 2024 {{productPurchaseHistory['072117'][0+7]}}
Jun- 2025 {{productPurchaseHistory['072117'][1]}} Nov- 2024 {{productPurchaseHistory['072117'][1+7]}}
May- 2025 {{productPurchaseHistory['072117'][2]}} Oct- 2024 {{productPurchaseHistory['072117'][2+7]}}
Apr- 2025 {{productPurchaseHistory['072117'][3]}} Sep- 2024 {{productPurchaseHistory['072117'][3+7]}}
Mar- 2025 {{productPurchaseHistory['072117'][4]}} Aug- 2024 {{productPurchaseHistory['072117'][4+7]}}
Feb- 2025 {{productPurchaseHistory['072117'][5]}} Jul- 2024 {{productPurchaseHistory['072117'][5+7]}}
Jan- 2025 {{productPurchaseHistory['072117'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}
Login

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

Ethiqa XR™ is an injectable suspension of extended-release buprenorphine. Buprenorphine hydrochloride, an opioid analgesic, is the active ingredient in Ethiqa XR. Lipid-bound buprenorphine hydrochloride is suspended in medium chain fatty acid triglyceride (MCT) oil. Lipids encapsulate the buprenorphine limiting diffusion which provides for larger doses and prolonged action. Ethiqa XR is indicated for the control of post-procedural pain in captive rodents, ferrets, laboratory rabbits, and non-human primates. For more information, consult the Prescribing Information including the Boxed Warning.

Features & Benefits

  • Proven long-acting extended-release technology
  • Delivers up to 72 hours of demonstrated therapeutic blood levels with one subcutaneous injection
  • One dose minimizes animal handling and stress and the inconvenience of multiple injections, helping improve animal welfare and reduce variability research
  • FDA-Indexed, not compounded or diluted
  • Once broached, Ethiqa XR™ should be discarded after 90 days